Advertisements



We are Sorry, This Page doesn't Exist


Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial

Shares of the biotech company Advaxis Inc. surged 68% in premarket trade on Friday after the Food and Drug Administration lifted a clinical hold on the company's phase 1/2 study for a cancer drug combination. The clinical hol.....»»

Category: topSource: marketwatchJul 13th, 2018

Asia shares rise for a third day, pound bewildered by politics

Asian shares rallied for a third session on Tuesday as hopes for upbeat corporate earnings buoyed Wall Street, while several high-profile resignations from Britain's government kept sterling on the defensive......»»

Category: topSource: reutersJul 10th, 2018

Market Snapshot: Stock market buoyed by trade-resolution hopes; investors await Fed commentary

U.S. stocks rise, buoyed by hopes the U.S. may temper plans to impose tariffs on European cars......»»

Category: topSource: marketwatchJul 5th, 2018

Market Snapshot: Stock market buoyed by Europe trade hopes; investors await Fed commentary

U.S. stocks rise, buoyed by hopes the U.S. may temper plans to impose tariffs on European cars......»»

Category: topSource: marketwatchJul 5th, 2018

Stocks rise on hopes for US concessions on auto tariffs

Stocks edged higher Thursday as the Trump administration reportedly hinted at concessions on tariffs against European cars......»»

Category: topSource: moneycentralJul 5th, 2018

Stocks rise on hopes for US concessions on auto tariffs

Stocks edged higher Thursday as the Trump administration reportedly hinted at concessions on tariffs against European cars......»»

Category: topSource: moneycentralJul 5th, 2018

Market Snapshot: Dow futures rise over 100 points as Ford, other auto makers gain on trade hopes

U.S. stock futures point to gains as investors return from the Fourth of July break. Auto makers were rising in premarket on hopes of a potential solution to trade tensions between the U.S. and Europe......»»

Category: topSource: marketwatchJul 5th, 2018

Roche to Pay $2.4 Billion for Full Control of Foundation Medicine

Roche said it would pay $2.4 billion to buy the shares it doesn’t already own in Foundation Medicine, furthering its bet on personalized cancer care......»»

Category: smallbizSource: wsjJun 19th, 2018

Pharma giant Roche just made a $2.4 billion bet on cancer data (FMI)

Reuters Roche on Tuesday bought the rest of Foundation Medicine, a company that collects genetic data from samples of cancer tissue or blood, for $2.4 billion. Roche .....»»

Category: topSource: businessinsiderJun 19th, 2018

Roche pays $2.4 billion for rest of cancer expert Foundation Medicine

ZURICH/LONDON (Reuters) - Swiss drugmaker Roche is paying $2.4 billion to buy the rest of Foundation Medicine (FMI) , raising its bet on the U.S. genomic profiling group's ability to personalize cancer care......»»

Category: topSource: reutersJun 19th, 2018

A blockbuster gene-editing tool has been linked to cancer — here"s how worried you should be

American Cancer Society/Getty Images Bold headlines linking blockbuster gene-editing tool CRISPR to cancer sent stocks in companies trying to bring the technology to medicine tumbling. But scientists who study the technique sa.....»»

Category: topSource: businessinsiderJun 13th, 2018

Crispr Therapeutics Falls As Studies Suggest Possible Cancerous Side Effect

Crispr Therapeutics AG (NASDAQ: CRSP) plunged more than 14 percent Monday after Nature Medicine published two studies warning that CRISPR-Cas9 might actually trigger cancer rather than treat targeted diseases. read more.....»»

Category: blogSource: benzingaJun 11th, 2018

CRISPR Crashes After Study Highlights Potential Cancer Risk From Gene-Editing

Don't mess with mother nature.. or crowded longs! Crispr Therapeutics led gene-editing stocks lower after new studies published by Nature Medicine found that cells whose genomes are edited with the CRISPR-Cas9 technology have the po.....»»

Category: blogSource: zerohedgeJun 11th, 2018

Bowel cancer is on the rise among millennials, according to a new study

American Cancer Society/Getty Images American Cancer Society researchers found a rise in the incidence of colorectal c.....»»

Category: topSource: businessinsiderJun 4th, 2018

DIGITAL HEALTH BRIEFING: Best Buy sees opportunities in healthcare — Patients uneasy with precision medicine — UnitedHealthcare adds value-based care partnerships

Welcome to DIGITAL .....»»

Category: topSource: businessinsiderMay 30th, 2018

Woman Claims to Beat Cancer With Anti-angiogenic Diet and Reiki, and Harvard Scientists Want to Know More

Harvard researchers are interested in individuals who have made amazing cancer recoveries, such as those who use diets and alternative medicine......»»

Category: topSource: newsweekMay 30th, 2018

US Stock Futures Rise on Korea Hopes; Oil Slumps: Markets Wrap - Bloomberg

BloombergUS Stock Futures Rise on Korea Hopes; Oil Slumps: Markets WrapBloombergU.S. equity .....»»

Category: topSource: googlenewsMay 28th, 2018

Europe Markets: European stocks score 4-month closing high, but Italy dents gain

European stocks rise Monday as U.S.-China trade tensions recede, fueling hopes a trade war can be averted, but jitters over Italian politics prove a drag on the region......»»

Category: topSource: marketwatchMay 21st, 2018

Stocks rise on hopes for breakthrough in US-China trade

Stocks traded higher on Monday amid hopes of a potential breakthrough in trade tensions between the U.S. and China, the world's two largest economies......»»

Category: topSource: moneycentralMay 14th, 2018

Stocks rise on hopes for breakthrough in US-China trade

Stocks traded higher on Monday amid hopes of a potential breakthrough in trade tensions between the U.S. and China, the world's two largest economies......»»

Category: topSource: moneycentralMay 14th, 2018